Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Sunshine Biopharma Inc.SBFM · Entity 8329 | 10% owner | October 10, 2016 | November 07, 2016 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Sunshine Biopharma Inc.
Report date October 10, 2016 · Filed November 07, 2016
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 215,014,224 |
Reported balance
After 2016-10-10 transaction · row 1
1 source rowRow 1 · 2016-10-10 · Other · Disposed 136,861,968 · Balance 215,014,224 F1: 136,861,968 shares were disposed of pursuant to a share exchange with an unrelated entity; no consideration was received as a result of the share exchange. |
Filing footnotes · ownership attribution and instrument terms
F1: 136,861,968 shares were disposed of pursuant to a share exchange with an unrelated entity; no consideration was received as a result of the share exchange.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 10, 2016 Filed Nov 7, 2016 17:10 UTC | Sunshine Biopharma Inc. SBFM · Entity 8329 | OtherCommon Stock | 136,861,968 | $0.00 | $0.00 |
DisclosureSEC source: 0001128732-16-000032 · primary_doc.xml · nonDerivative · entry 1 Advanomics Corp · CIK 0001681176 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 215,014,224 F1 · kind: 136,861,968 shares were disposed of pursuant to a share exchange with an unrelated entity; no consideration was received as a result of the share exchange. F1 · price: 136,861,968 shares were disposed of pursuant to a share exchange with an unrelated entity; no consideration was received as a result of the share exchange. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.